"The microdosing strategy has some attractive benefits, including helping to mitigate side effects and being able to customize the dose to the minimum efficacious dose for individual patients," says Katie Sorensen , a nurse practitioner specializing in GLP-1 medications who was not involved in Burgess' treatment
The case that suggests harm However, a 2025 case report tells a very different story
The question is whether achieving them pharmacologically introduces imbalances the endogenous system would naturally prevent
If you have kidney disease, your body may not be able to easily clear magnesium, which can build up and lead to side effects such as weakness, low blood pressure, and heart rhythm problems
Industry analysts also suggest that GLP-1 users may prioritise products that deliver higher levels of protein, fibre and hydration in smaller portions, reflecting both reduced appetite and changing dietary priorities